GRK6 has been reported as a potential biomarker enriched in prostate cancer cell exosomes.[18] Aberrant expression of GRK6 was associated with dismal prognosis in multiple cancer types.[19–21] Another prognosis-related gene, IL3RA, is highly expressed on the surface of multiple cells. The gene discussed is IL3RA; the disease is prostate carcinoma.